Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment
VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma
VHL Gene Mutations and Their Effects on Hypoxia Inducible Factor HIF alpha: Identification of Potential Driver and Passenger Mutations
VHL Inactivation in Precancerous Kidney Cells Induces an Inflammatory Response via ER Stress-Activated IRE1 alpha Signaling
VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2
VHL Brings Warburg into the Memory Spotlight
VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIF alpha degradation in clear cell renal cell carcinoma
VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin
VHL promotes immune response against renal cell carcinoma via NF-kappa B-dependent regulation of VCAM-1
VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma
VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease
VHL mosaicism can be detected by clinical next-generation sequencing and is not restricted to patients with a mild phenotype
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
VHL loss predicts response to Aurora kinase A inhibitor in renal cell carcinoma cells
VHL, the story of a tumour suppressor gene
VHL-deficient vasculogenesis in hemangioblastoma
VHL-mediated disruption of Sox9 activity compromises beta-cell identity and results in diabetes mellitus
VHL-gene Deletion in Single Renal Tubular Epithelial Cells and Renal Tubular Cysts: Further Evidence for a Cyst-dependent Progression Pathway of Clear Cell Renal Carcinoma in von Hippel-Lindau Disease
VHL-dependent regulation of a beta-dystroglycan glycoform and glycogene expression in renal cancer
VHL-Regulated MiR-204 Suppresses Tumor Growth through Inhibition of LC3B-Mediated Autophagy in Renal Clear Cell Carcinoma
VHL-TGFBI signaling is involved in the synergy between 5-aza-2 '-deoxycytidine and paclitaxel against human renal cell carcinoma
VHL-deficient renal cancer cells gain resistance to mitochondria-activating apoptosis inducers by activating AKT through the IGF1R-PI3K pathway
VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response?
VHL/HIF信号转导通路在骨发育及相关疾病中的调控机制
VHL: Cullin-g the Hypoxic Response